BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 19668233)

  • 1. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
    Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
    Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
    Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
    Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha.
    Mori A; Moser C; Lang SA; Hackl C; Gottfried E; Kreutz M; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Res; 2009 Aug; 7(8):1390-8. PubMed ID: 19671674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization.
    Liu R; Zheng HQ; Zhou Z; Dong JT; Chen C
    J Biol Chem; 2009 Jun; 284(25):16791-16798. PubMed ID: 19411256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer.
    Tong D; Czerwenka K; Heinze G; Ryffel M; Schuster E; Witt A; Leodolter S; Zeillinger R
    Clin Cancer Res; 2006 Apr; 12(8):2442-8. PubMed ID: 16638850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
    Lee MY; Moon JS; Park SW; Koh YK; Ahn YH; Kim KS
    Biochem J; 2009 Jan; 417(1):313-22. PubMed ID: 18774944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
    Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
    Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer.
    Chen C; Bhalala HV; Qiao H; Dong JT
    Oncogene; 2002 Sep; 21(43):6567-72. PubMed ID: 12242654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
    Zhi X; Zhao D; Zhou Z; Liu R; Chen C
    Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
    Nilsson EM; Brokken LJ; Härkönen PL
    Exp Cell Res; 2010 Mar; 316(5):800-12. PubMed ID: 19962979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Krüppel-like factor 4 represses transcription of the survivin gene in esophageal cancer cell lines.
    Zhang G; Zhu H; Wang Y; Yang S; Liu M; Zhang W; Quan L; Bai J; Liu Z; Xu N
    Biol Chem; 2009; 390(5-6):463-9. PubMed ID: 19361279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
    Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
    Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N; Hill AD; Young LS
    J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation.
    Oishi Y; Manabe I; Tobe K; Tsushima K; Shindo T; Fujiu K; Nishimura G; Maemura K; Yamauchi T; Kubota N; Suzuki R; Kitamura T; Akira S; Kadowaki T; Nagai R
    Cell Metab; 2005 Jan; 1(1):27-39. PubMed ID: 16054042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
    Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
    Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
    Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
    Shain SA
    Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
    Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
    Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens.
    Takagi K; Miki Y; Onodera Y; Nakamura Y; Ishida T; Watanabe M; Inoue S; Sasano H; Suzuki T
    Endocr Relat Cancer; 2012 Dec; 19(6):741-50. PubMed ID: 22936544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.